Renal Failure Acute Chronic

3

Review clinical trials related to Renal Failure Acute Chronic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Impact of Trans-catheter Aortic Valve Implantation on Renal Function

Both contrast-induced acute kidney injury (AKI) and pre-existing chronic kidney disease are associated with an increased mortality risk in patients requiring aortic valve replacement. Nonetheless, the direct haemodynamic impact of the aortic barrage (i.e. pre-renal mechanism) on renal function compromising and its reversibility in patients undergoing trans-catheter aortic valve implantation (TAVI) is unknown. This registry aims to evaluate the effect of severe aortic stenosis removal on the risk of contrast-induced acute renal injury (CI-AKI) during TAVI procedures and on renal function evolution

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSUpdated: Jun 4, 2026Locations: 1Duration: 5 Years
Eligibility criteria

Age >18 years with a life expectancy >1 year; [+4]

Female with childbearing potential or lactating; [+5]

Status: Recruiting

Bispectral-Electroencephalography (EEG) in First Time Hemodialysis

The severity of minimal dialysis disequilibrium syndrome (DDS) is currently detected and graded clinically using clinical criteria. Bispectral Index (BIS), an electroencephalographic (EEG) derived parameter is widely used in anesthesia and Critical Care setting to detect effects of anesthetic/hypnotic drugs. The aim of our study was to assess the discriminative power of BIS monitoring to accurately detect DDS.

Participants needed: 20
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Suez Canal UniversityUpdated: Apr 28, 2026Locations: 2
Eligibility criteria

First Time renal Dialysis

subjects' consumption of sedatives/hypnotics psychotropic drugs, or concomitant...

Status: Not yet recruiting

Efficacy and Tolerability of the APD Treatment in PAED Patients

The Silencia PD (peritoneal dialysis) cycler offers a pediatric (PAED) mode with advanced features such as Time and Volume Optimization (TAVO), supporting precise and individualized treatment. This study evaluates the efficacy and tolerability of Automated Peritoneal Dialysis (APD) using the Silencia PD cycler in patients weighing ≤ 20 kg and able to tolerate a minimum inflow volume of 100 mL. The primary objective is to determine whether patients achieve a total weekly Kt/Vurea ≥ 1.8.

Participants needed: 13
Trial details
Age: 0+Biological sex: AllType: InterventionalSponsor: Fresenius Medical Care Deutschland GmbHUpdated: Jun 4, 2025
Eligibility criteria

Informed consent signed and dated by legal representative and investigator/autho... [+5]

Any conditions which could interfere with the patient's ability to comply with t... [+5]